|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9200 AUD | +1.10% |
|
-3.16% | -15.21% |
| 02/02 | Orthocell Eyes Fiscal 2027 Entry Into UK, European Union Markets | MT |
| 19/01 | Orthocell posts quarterly revenue of A$3.2 million | RE |
Company Valuation: Orthocell Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Capitalization 1 | 79.84 | 285.9 | 246.9 | - | - |
| Change | - | - | -13.65% | - | - |
| Enterprise Value (EV) 1 | 79.84 | 285.9 | 203.2 | 210.8 | 215.6 |
| Change | - | - | -28.94% | 3.74% | 2.28% |
| P/E ratio | -8.62x | -30.9x | - | - | - |
| PBR | - | - | - | - | - |
| PEG | - | - | - | - | - |
| Capitalization / Revenue | - | - | 17.8x | 10.2x | 5.17x |
| EV / Revenue | - | - | 14.6x | 8.75x | 4.51x |
| EV / EBITDA | - | - | -17.1x | -30.1x | 93.7x |
| EV / EBIT | - | - | -15.4x | -24x | -2,156x |
| EV / FCF | - | - | -16.3x | -24.5x | -38.5x |
| FCF Yield | - | - | -6.15% | -4.08% | -2.6% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.047 | -0.038 | - | - | - |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | - | 13.9 | 24.1 | 47.8 |
| EBITDA 1 | - | - | -11.9 | -7 | 2.3 |
| EBIT 1 | - | - | -13.2 | -8.8 | -0.1 |
| Net income | -9.107 | -8.567 | - | - | - |
| Net Debt 1 | - | - | -43.7 | -36.1 | -31.3 |
| Reference price 2 | 0.4050 | 1.1750 | 0.9100 | 0.9100 | 0.9100 |
| Nbr of stocks (in thousands) | 1,97,128 | 2,43,344 | 2,71,308 | - | - |
| Announcement Date | 30/08/22 | 29/08/25 | - | - | - |
1AUD in Million2AUD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 14.62x | -17.07x | - | 17Cr | ||
| 30.39x | 5.25x | 20.75x | 0.31% | 20TCr | ||
| 55.25x | 14.3x | 33.4x | -.--% | 17TCr | ||
| 41.55x | 6.79x | 22.01x | 0.58% | 15TCr | ||
| 37.41x | 6.07x | 19.81x | -.--% | 11TCr | ||
| 20.46x | 2.36x | 11.61x | 2.56% | 5.46TCr | ||
| 34.77x | 6.99x | 23.13x | -.--% | 4.57TCr | ||
| 25.66x | 6.82x | 17.52x | 0.9% | 3.96TCr | ||
| 16.94x | 1.9x | 10.28x | 0.19% | 3.68TCr | ||
| 24.3x | 5.1x | 17.76x | 0.79% | 3.67TCr | ||
| Average | 31.86x | 7.02x | 15.92x | 0.59% | 8.57TCr | |
| Weighted average by Cap. | 36.89x | 7.30x | 22.22x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- OCC Stock
- Valuation Orthocell Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















